Special Session

Presidential Symposium II - EL10 - RT for Metastatic GI Cancer Improves Patient Prognosis

9/15/2019
10:15 AM - 11:45 AM
Location: Room W187

Session Type: Special Session
0.00 AMA PRA Category 1 Credits™

In this session, we hope to engage audience members in an entertaining and interactive format to debate the topic of whether or not radiation therapy can improve outcomes in patients with oligometastatic GI cancer. We will specifically address this question for 2 case scenarios: 1) metastatic colorectal cancer and 2) metastatic pancreatic cancer.

During this session audience members will be asked to participate in case-based discussion and a "Shark Tank" style debate where attendees will be assigned a Pro or Con viewpoint for radiotherapy in a case scenario in front of a panel of volunteer judges. The judges will then determine the winners of each debate based on the quality of their arguments.

Through the spirit of fun and healthy competition, we hope to challenge the prevailing concept that only systemic therapy is indicated in the setting of metastatic disease given the advancements in systemic therapy which have opened the door for aggressive local therapy in these patients. The session will end with a wrap up and take-home message.

Presentations:

Daniel Chang, MD

Stanford University

Presentation(s):

Send Email for Daniel Chang

Amol Narang, MD

Johns Hopkins University

Presentation(s):

Send Email for Amol Narang

Emma Holliday, MD

MD Anderson Cancer Center

Disclosure:
Employment
The University of Texas MD Anderson Cancer Center

Compensation
Merck: Research Grant

Presentation(s):

Send Email for Emma Holliday


Assets

Presidential Symposium II - EL10 - RT for Metastatic GI Cancer Improves Patient Prognosis



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Presidential Symposium II - EL10 - RT for Metastatic GI Cancer Improves Patient Prognosis